33009401 |
SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate
Nielsen, CG,
Hoang, HD,
Knudsen, A,
van der Horst, D,
Holm, CK,
Alain, T,
Peri, S,
Thomsen, M,
Lappe, M,
Luo, Y,
Hansen, AL,
Balachandran, S,
Idorn, M,
Hait, A,
Iversen, MB,
Svenningsen, EB,
Møller, C,
Reinert, LS,
Hernaez, B,
Mogensen, TH,
Thyrsted, J,
Jørgensen, SE,
Bartsch, L,
Rehwinkel, J,
Huang, J,
Ottosen, R,
Blay-Cadanet, J,
Thielke, AL,
Paludan, SR,
Hiscott, J,
Jakobsen, M,
Poulsen, TB,
Herengt, A,
Schilling, M,
Farahani, E,
Gilchrist, VH,
Olagnier, D,
Alcamí, A
|
Nat Commun |
2020 |
33791708 |
Sulforaphane exhibits in vitro and in vivo antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses
Thompson, EA,
Villabona-Rueda, AF,
Bullen, CK,
Ordonez, AA,
Davis, SL,
Yolken, RH,
Komm, O,
Turner, ML,
Jones-Brando, L,
D'Alessio, FR,
Powell, JD,
Jain, SK
|
bioRxiv |
2021 |
30610225 |
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Wells, G,
Cousin, SP,
Franklin, S,
Cuadrado, A,
Rojo, AI,
Hayes, JD,
Rumsey, WL,
Levonen, AL,
Dinkova-Kostova, AT,
Kensler, TW,
Attucks, OC
|
Nat Rev Drug Discov |
2019 |